Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Shelter Pharma's Enterprise Value is ₹418.7 Mil.
Shelter Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-140.7 Mil. Therefore, Shelter Pharma's EV-to-FCF for today is -2.98.
The historical rank and industry rank for Shelter Pharma's EV-to-FCF or its related term are showing as below:
BOM:543963'
s EV-to-FCF Range Over the Past 10 Years
Min: -84.89 Med: -16.89 Max: 18.78
Current: -2.98
During the past 7 years, the highest EV-to-FCF of Shelter Pharma was 18.78. The lowest was -84.89. And the median was -16.89.
BOM:543963's EV-to-FCF is ranked worse than 100% of 561
companies
in the Drug Manufacturers industry
Industry Median: 21.29
vs BOM:543963: -2.98
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shelter Pharma's PE Ratio (TTM) for today is calculated as:
Shelter Pharma's share price for today is ₹25.20.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shelter Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4.890.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Shelter Pharma EV-to-FCF Related Terms
Shelter Pharma EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Shelter Pharma's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Shelter Pharma's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shelter Pharma EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shelter Pharma's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Shelter Pharma's EV-to-FCF falls into.
Shelter Pharma's current Enterprise Value is ₹418.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shelter Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-140.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shelter Pharma (BOM:543963) has a EV-to-FCF of -2.98 as of Aug. 16, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shelter Pharma and its competitors. According to the industry distribution chart, Shelter Pharma ranks #999999 out of 561 companies in the Drug Manufacturers industry.
Is Shelter Pharma's EV-to-FCF too high?
Shelter Pharma's current EV-to-FCF is -2.98. Based on the distribution chart, Shelter Pharma ranks #999999 out of 561 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Shelter Pharma has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shelter Pharma's EV-to-FCF compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Shelter Pharma ranks #999999 out of 561 companies for EV-to-FCF. This places Shelter Pharma in the lower half of its industry. The industry median EV-to-FCF is 21.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 21.29, based on 561 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shelter Pharma and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 21.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shelter Pharma's current EV-to-FCF is -2.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shelter Pharma stock overvalued right now?
Based on GuruFocus' analysis, Shelter Pharma (BOM:543963) is currently considered Possible Value Trap. The stock's GF Value™ is ₹57.14, compared to a current price of ₹25.20 — trading 55.9% below its estimated fair value. The current EV-to-FCF is -2.98. Shelter Pharma's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Shelter Pharma (BOM:543963), the current EV-to-FCF is -2.98 as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shelter Pharma (BOM:543963) Overvalued in 2026?
Based on GuruFocus' analysis, Shelter Pharma stock appears to be undervalued.
The current stock price of ₹25.20 is trading 55.9% below its estimated GF Value™ of ₹57.14.
GuruFocus considers Shelter Pharma to be Possible Value Trap.
Key valuation signals for BOM:543963:
EV-to-FCF: -2.98
GF Value™: ₹57.14 vs. price of ₹25.20 (55.9% below fair value)
No single metric tells the full story. See the BOM:543963 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shelter Pharma Ltd focuses in manufacturing herbal products with a well-built presence in Human Pharma as well as the Veterinary space. It is present in majority of the non-critical segments of human and veterinary pharma through its well-spread portfolio. Its products include tablets, syrups, baby drops, barley water, oils, powders, ointments, etc.
66GF Score
Get the complete analysis for BOM:543963
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543963 has been successfully added to your 
